| 标题 |
Patient-reported outcomes from the MIRASOL trial evaluating mirvetuximab soravtansine versus chemotherapy in patients with folate receptor α-positive, platinum-resistant ovarian cancer: a randomised, open-label, phase 3 trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet. Oncology 作者:Van Gorp T; Moore KN; Konecny GE; Leary A; García-García Y; et al 出版日期:2025/04/01 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)